CompletedNCT04760652
CBT after esketamine for depression and suicidal thoughts
About this title
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Read the official source — NCT04760652Behavioural studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Birmingham and 2 more locationsSee all locations and recruitment
Study information
Study start dateStarted: March 5, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 93
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Other
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04760652
- Official title
Show the full official title
CBT-ENDURE: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · New Haven · Atlanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Who was this study for?
Listed age limits: 18 years to 65 years.
